Abstract:The present study aimed to explore the potential clinical significance of microRNA (miR)-124-3p expression in the hepatocarcinogenesis and development of hepatocellular carcinoma (HCC), as well as the potential target genes of functional HCC pathways. Reverse transcription-quantitative polymerase chain reaction was performed to evaluate the expression of miR-124-3p in 101 HCC and adjacent non-cancerous tissue samples. Additionally, the association between miR-124-3p expression and clinical parameters was also analyzed. Differentially expressed genes identified following miR-124-3p transfection, the prospective target genes predicted in silico and the key genes of HCC obtained from Natural Language Processing (NLP) were integrated to obtain potential target genes of miR-124-3p in HCC. Relevant signaling pathways were assessed with protein-protein interaction (PPI) networks, Gene Ontology (GO) enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) and Protein Annotation Through Evolutionary Relationships (PANTHER) pathway enrichment analysis. miR-124-3p expression was significantly reduced in HCC tissues compared with expression in adjacent non-cancerous liver tissues. In HCC, miR-124-3p was demonstrated to be associated with clinical stage. The mean survival time of the low miR-124-3p expression group was reduced compared with that of the high expression group. A total of 132 genes overlapped from differentially expressed genes, miR-124-3p predicted target genes and NLP identified genes. PPI network construction revealed a total of 109 nodes and 386 edges, and 20 key genes were identified. The major enriched terms of three GO categories included regulation of cell proliferation, positive regulation of cellular biosynthetic processes, cell leading edge, cytosol and cell projection, protein kinase activity, transcription activator activity and enzyme binding. KEGG analysis revealed pancreatic cancer, prostate cancer and non-small cell lung cancer as the top three terms. Angiogenesis, the endothelial growth factor receptor signaling pathway and the fibroblast growth factor signaling pathway were identified as the most significant terms in the PANTHER pathway analysis. The present study confirmed that miR-124-3p acts as a tumor suppressor in HCC. miR-124-3p may target multiple genes, exerting its effect spatiotemporally, or in combination with a diverse range of processes in HCC. Functional characterization of miR-124-3p targets will offer novel insight into the molecular changes that occur in HCC progression.

Mir-124 Inhibits Progression of Hepatocarcinoma by Targeting KLF4 and Promises a Novel Diagnostic Marker

MiR-144-3p-mediated Dysregulation of EIF4G2 Contributes to the Development of Hepatocellular Carcinoma Through the ERK Pathway

MicroRNA‐122 Suppresses Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma by Directly Targeting Wnt/β‐catenin Pathway

Mir-424-3p Promotes Metastasis of Hepatocellular Carcinoma Via Targeting the SRF-STAT1/2 Axis.

MicroRNA Mir-124-3p Suppresses Proliferation and Epithelial–mesenchymal Transition of Hepatocellular Carcinoma Via ARRDC1 (arrestin Domain Containing 1)

Mir-1204 Promotes Hepatocellular Carcinoma Progression Through Activating MAPK and C-Jun/ap1 Signaling by Targeting ZNF418

The Putative Tumour Suppressor Microrna-124 Modulates Hepatocellular Carcinoma Cell Aggressiveness by Repressing Rock2 and Ezh2

MiR-7 Inhibits Progression of Hepatocarcinoma by Targeting KLF-4 and Promises a Novel Diagnostic Biomarker

Methylation-regulated Mir-124-1 Suppresses Tumorigenesis in Hepatocellular Carcinoma by Targeting CASC3

Downregulated Mir-1247-5p Associates with Poor Prognosis and Facilitates Tumor Cell Growth Via DVL1/Wnt/β-catenin Signaling in Breast Cancer

MiR-124 Inhibits the Migration and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing Integrin Αv Expression.

Ectopic Expression Of Mir-125a Inhibits The Proliferation And Metastasis Of Hepatocellular Carcinoma By Targeting Mmp11 And Vegf

MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study

MiRNA-124 inhibits the proliferation, migration and invasion of cancer cell in hepatocellular carcinoma by downregulating lncRNA-UCA1

Microrna-134 Inhibits Hcc Cell Growth And Migration Through The Akt/Gsk3 Beta/Snail Signaling Pathway

Klf4 Inhibits Tumor Growth and Metastasis by Targeting Microrna-31 in Human Hepatocellular Carcinoma

Mir-187-3p Inhibits the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting S100A4.

Mir-876 Inhibits EMT and Liver Fibrosis Via POSTN to Suppress Metastasis in Hepatocellular Carcinoma

Reduced Hsa-Mir-124-3p Levels Are Associated with the Poor Survival of Patients with Hepatocellular Carcinoma

MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.

Mir-654-3p Predicts the Prognosis of Hepatocellular Carcinoma and Inhibits the Proliferation, Migration, and Invasion of Cancer Cells